CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01092897
NCT01092897N/ACompleted
CompareCT.gov

Biomarkers in Pulmonary Arterial Hypertension Treated With Imatinib

The Cleveland Clinic·observational·Posted Mar 25, 2010·Updated Feb 4, 2014

In Brief

An observational study for PAH. Completed, enrolled 130 participants across 8 sites.

Detailed Summary

The purpose of the study is to determine whether circulating molecular and cellular biomarkers are predictive of imatinib effect on pulmonary artery hypertension.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPAH
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 25, 2010
Enrollment StartMar 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 16.3 years ago